|
2024
|
Invention
|
Treatment of amyotrophic lateral sclerosis using pkc activators.
A method for treating or preven... |
|
|
Invention
|
Methods of treating and preventing neurodegenerative diseases with hgf activating compounds.
A m... |
|
|
Invention
|
Methods for repairing nerve damage using pkc activating therapeutic agents. A method for treating... |
|
|
Invention
|
Methods for repairing nerve damage using pkc activating therapeutic agents.
A method for treatin... |
|
2023
|
Invention
|
Pkc-activating compounds for the treatment of neurodegenerative diseases.
The present invention ... |
|
|
Invention
|
Method of enhancing recovery from long covid. A method for treating or preventing long COVID in a... |
|
2022
|
Invention
|
Pkc-activating compounds for the treatment of neurodegenerative diseases. The present invention r... |
|
|
Invention
|
Method of inducing synaptogenesis by administering angiotensin and analogues thereof. A method fo... |
|
|
Invention
|
Treatment of multiple sclerosis using pkc activators.
A method for treating or preventing mild, ... |
|
|
Invention
|
Treatment of optic nerve inflammation using pkc activators.
A method for treating or preventing ... |
|
|
Invention
|
Treatment of multiple sclerosis using pkc activators. A method for treating or preventing mild, m... |
|
|
Invention
|
Treatment of optic nerve inflammation using pkc activators. A method for treating or preventing o... |
|
|
Invention
|
Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurode... |
|
2021
|
Invention
|
Treatment of amyotrophic lateral sclerosis using pkc activators. A method for treating or prevent... |
|
|
Invention
|
Methods of treating and preventing neurodegenerative diseases with hgf activating compounds. A me... |
|
|
Invention
|
Method of inducing synaptogenesis by administering angiotensin and analogues thereof.
A method f... |
|
|
Invention
|
Methods and compositions for treatment of alzheimer's disease and other neurodegenerative disorde... |
|
2020
|
Invention
|
Dosing regimens of pkc activators. Dosing regimens and methods are disclosed for upregulating pro... |
|
|
Invention
|
Methods for inducing synaptogenesis with synaptic growth factor activating compounds. A method fo... |
